LY96 and ablepharon macrostomia syndrome: While previous studies have identified HMGB1, TRL4, LY96, ANGPTL4, VEGFA, and IL10 as potential inflammation-related markers for AMS, the present study found that only HMGB1, LY96, and VEGFA were detectable, but not significantly differentially expressed.